Global Pharma Ophthalmic Market Insights and Forecast to 2026

Global Pharma Ophthalmic Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pharma Ophthalmic Product Introduction
1.2 Market Segments
1.3 Key Pharma Ophthalmic Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pharma Ophthalmic Market Size Growth Rate by Type
1.4.2 Retinal disorders drugs
1.4.3 Allergic, inflammatory and infective drugs
1.4.4 Glaucoma drugs
1.4.5 Dry eye drugs
1.4.6 Other ophthalmic drugs
1.5 Market by Application
1.5.1 Global Pharma Ophthalmic Market Size Growth Rate by Application
1.5.2 Glaucoma
1.5.3 Dry eye syndrome
1.5.4 Retinal diseases
1.5.5 Other ophthalmic indications
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pharma Ophthalmic Market Size, Estimates and Forecasts
2.1.1 Global Pharma Ophthalmic Revenue 2015-2026
2.1.2 Global Pharma Ophthalmic Sales 2015-2026
2.2 Global Pharma Ophthalmic, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pharma Ophthalmic Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pharma Ophthalmic Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pharma Ophthalmic Competitor Landscape by Players
3.1 Pharma Ophthalmic Sales by Manufacturers
3.1.1 Pharma Ophthalmic Sales by Manufacturers (2015-2020)
3.1.2 Pharma Ophthalmic Sales Market Share by Manufacturers (2015-2020)
3.2 Pharma Ophthalmic Revenue by Manufacturers
3.2.1 Pharma Ophthalmic Revenue by Manufacturers (2015-2020)
3.2.2 Pharma Ophthalmic Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pharma Ophthalmic Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pharma Ophthalmic Revenue in 2019
3.2.5 Global Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pharma Ophthalmic Price by Manufacturers
3.4 Pharma Ophthalmic Manufacturing Base Distribution, Product Types
3.4.1 Pharma Ophthalmic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pharma Ophthalmic Product Type
3.4.3 Date of International Manufacturers Enter into Pharma Ophthalmic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pharma Ophthalmic Market Size by Type (2015-2020)
4.1.1 Global Pharma Ophthalmic Sales by Type (2015-2020)
4.1.2 Global Pharma Ophthalmic Revenue by Type (2015-2020)
4.1.3 Pharma Ophthalmic Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pharma Ophthalmic Market Size Forecast by Type (2021-2026)
4.2.1 Global Pharma Ophthalmic Sales Forecast by Type (2021-2026)
4.2.2 Global Pharma Ophthalmic Revenue Forecast by Type (2021-2026)
4.2.3 Pharma Ophthalmic Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pharma Ophthalmic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pharma Ophthalmic Market Size by Application (2015-2020)
5.1.1 Global Pharma Ophthalmic Sales by Application (2015-2020)
5.1.2 Global Pharma Ophthalmic Revenue by Application (2015-2020)
5.1.3 Pharma Ophthalmic Price by Application (2015-2020)
5.2 Pharma Ophthalmic Market Size Forecast by Application (2021-2026)
5.2.1 Global Pharma Ophthalmic Sales Forecast by Application (2021-2026)
5.2.2 Global Pharma Ophthalmic Revenue Forecast by Application (2021-2026)
5.2.3 Global Pharma Ophthalmic Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pharma Ophthalmic by Country
6.1.1 North America Pharma Ophthalmic Sales by Country
6.1.2 North America Pharma Ophthalmic Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pharma Ophthalmic Market Facts & Figures by Type
6.3 North America Pharma Ophthalmic Market Facts & Figures by Application
7 Europe
7.1 Europe Pharma Ophthalmic by Country
7.1.1 Europe Pharma Ophthalmic Sales by Country
7.1.2 Europe Pharma Ophthalmic Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pharma Ophthalmic Market Facts & Figures by Type
7.3 Europe Pharma Ophthalmic Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pharma Ophthalmic by Region
8.1.1 Asia Pacific Pharma Ophthalmic Sales by Region
8.1.2 Asia Pacific Pharma Ophthalmic Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pharma Ophthalmic Market Facts & Figures by Type
8.3 Asia Pacific Pharma Ophthalmic Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pharma Ophthalmic by Country
9.1.1 Latin America Pharma Ophthalmic Sales by Country
9.1.2 Latin America Pharma Ophthalmic Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pharma Ophthalmic Market Facts & Figures by Type
9.3 Central & South America Pharma Ophthalmic Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pharma Ophthalmic by Country
10.1.1 Middle East and Africa Pharma Ophthalmic Sales by Country
10.1.2 Middle East and Africa Pharma Ophthalmic Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pharma Ophthalmic Market Facts & Figures by Type
10.3 Middle East and Africa Pharma Ophthalmic Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Pharma Ophthalmic Products Offered
11.1.5 Novartis Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description and Business Overview
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Pharma Ophthalmic Products Offered
11.2.5 Allergan Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Pharma Ophthalmic Products Offered
11.3.5 Roche Related Developments
11.4 Valeant
11.4.1 Valeant Corporation Information
11.4.2 Valeant Description and Business Overview
11.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Valeant Pharma Ophthalmic Products Offered
11.4.5 Valeant Related Developments
11.5 Regeneron
11.5.1 Regeneron Corporation Information
11.5.2 Regeneron Description and Business Overview
11.5.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Regeneron Pharma Ophthalmic Products Offered
11.5.5 Regeneron Related Developments
11.6 Santen
11.6.1 Santen Corporation Information
11.6.2 Santen Description and Business Overview
11.6.3 Santen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Santen Pharma Ophthalmic Products Offered
11.6.5 Santen Related Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Description and Business Overview
11.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bayer Pharma Ophthalmic Products Offered
11.7.5 Bayer Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Pharma Ophthalmic Products Offered
11.8.5 Pfizer Related Developments
11.9 Senju
11.9.1 Senju Corporation Information
11.9.2 Senju Description and Business Overview
11.9.3 Senju Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Senju Pharma Ophthalmic Products Offered
11.9.5 Senju Related Developments
11.10 Akorn
11.10.1 Akorn Corporation Information
11.10.2 Akorn Description and Business Overview
11.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Akorn Pharma Ophthalmic Products Offered
11.10.5 Akorn Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Pharma Ophthalmic Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pharma Ophthalmic Market Estimates and Projections by Region
12.1.1 Global Pharma Ophthalmic Sales Forecast by Regions 2021-2026
12.1.2 Global Pharma Ophthalmic Revenue Forecast by Regions 2021-2026
12.2 North America Pharma Ophthalmic Market Size Forecast (2021-2026)
12.2.1 North America: Pharma Ophthalmic Sales Forecast (2021-2026)
12.2.2 North America: Pharma Ophthalmic Revenue Forecast (2021-2026)
12.2.3 North America: Pharma Ophthalmic Market Size Forecast by Country (2021-2026)
12.3 Europe Pharma Ophthalmic Market Size Forecast (2021-2026)
12.3.1 Europe: Pharma Ophthalmic Sales Forecast (2021-2026)
12.3.2 Europe: Pharma Ophthalmic Revenue Forecast (2021-2026)
12.3.3 Europe: Pharma Ophthalmic Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pharma Ophthalmic Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pharma Ophthalmic Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pharma Ophthalmic Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pharma Ophthalmic Market Size Forecast by Region (2021-2026)
12.5 Latin America Pharma Ophthalmic Market Size Forecast (2021-2026)
12.5.1 Latin America: Pharma Ophthalmic Sales Forecast (2021-2026)
12.5.2 Latin America: Pharma Ophthalmic Revenue Forecast (2021-2026)
12.5.3 Latin America: Pharma Ophthalmic Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pharma Ophthalmic Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pharma Ophthalmic Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pharma Ophthalmic Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pharma Ophthalmic Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pharma Ophthalmic Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pharma Ophthalmic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pharma Ophthalmic Market Segments
Table 2. Ranking of Global Top Pharma Ophthalmic Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pharma Ophthalmic Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Retinal disorders drugs
Table 5. Major Manufacturers of Allergic, inflammatory and infective drugs
Table 6. Major Manufacturers of Glaucoma drugs
Table 7. Major Manufacturers of Dry eye drugs
Table 8. Major Manufacturers of Other ophthalmic drugs
Table 9. Global Pharma Ophthalmic Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Pharma Ophthalmic Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Pharma Ophthalmic Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Pharma Ophthalmic Sales Market Share by Regions (2015-2020)
Table 13. Global Pharma Ophthalmic Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Pharma Ophthalmic Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Pharma Ophthalmic Sales Share by Manufacturers (2015-2020)
Table 16. Global Pharma Ophthalmic Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Pharma Ophthalmic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma Ophthalmic as of 2019)
Table 18. Pharma Ophthalmic Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Pharma Ophthalmic Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Pharma Ophthalmic Price (2015-2020) (USD/Pcs)
Table 21. Pharma Ophthalmic Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pharma Ophthalmic Product Type
Table 23. Date of International Manufacturers Enter into Pharma Ophthalmic Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharma Ophthalmic Sales by Type (2015-2020) (K Pcs)
Table 26. Global Pharma Ophthalmic Sales Share by Type (2015-2020)
Table 27. Global Pharma Ophthalmic Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Pharma Ophthalmic Revenue Share by Type (2015-2020)
Table 29. Pharma Ophthalmic Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Pharma Ophthalmic Sales by Application (2015-2020) (K Pcs)
Table 31. Global Pharma Ophthalmic Sales Share by Application (2015-2020)
Table 32. North America Pharma Ophthalmic Sales by Country (2015-2020) (K Pcs)
Table 33. North America Pharma Ophthalmic Sales Market Share by Country (2015-2020)
Table 34. North America Pharma Ophthalmic Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Pharma Ophthalmic Revenue Market Share by Country (2015-2020)
Table 36. North America Pharma Ophthalmic Sales by Type (2015-2020) (K Pcs)
Table 37. North America Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 38. North America Pharma Ophthalmic Sales by Application (2015-2020) (K Pcs)
Table 39. North America Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 40. Europe Pharma Ophthalmic Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Pharma Ophthalmic Sales Market Share by Country (2015-2020)
Table 42. Europe Pharma Ophthalmic Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Pharma Ophthalmic Revenue Market Share by Country (2015-2020)
Table 44. Europe Pharma Ophthalmic Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 46. Europe Pharma Ophthalmic Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Pharma Ophthalmic Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Pharma Ophthalmic Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Pharma Ophthalmic Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Pharma Ophthalmic Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Pharma Ophthalmic Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Pharma Ophthalmic Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 56. Latin America Pharma Ophthalmic Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Pharma Ophthalmic Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Pharma Ophthalmic Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Pharma Ophthalmic Revenue Market Share by Country (2015-2020)
Table 60. Latin America Pharma Ophthalmic Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 62. Latin America Pharma Ophthalmic Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Pharma Ophthalmic Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Pharma Ophthalmic Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pharma Ophthalmic Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Pharma Ophthalmic Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pharma Ophthalmic Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Pharma Ophthalmic Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Table 72. Novartis Corporation Information
Table 73. Novartis Description and Major Businesses
Table 74. Novartis Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Novartis Product
Table 76. Novartis Recent Development
Table 77. Allergan Corporation Information
Table 78. Allergan Description and Major Businesses
Table 79. Allergan Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Allergan Product
Table 81. Allergan Recent Development
Table 82. Roche Corporation Information
Table 83. Roche Description and Major Businesses
Table 84. Roche Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Roche Product
Table 86. Roche Recent Development
Table 87. Valeant Corporation Information
Table 88. Valeant Description and Major Businesses
Table 89. Valeant Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Valeant Product
Table 91. Valeant Recent Development
Table 92. Regeneron Corporation Information
Table 93. Regeneron Description and Major Businesses
Table 94. Regeneron Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Regeneron Product
Table 96. Regeneron Recent Development
Table 97. Santen Corporation Information
Table 98. Santen Description and Major Businesses
Table 99. Santen Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Santen Product
Table 101. Santen Recent Development
Table 102. Bayer Corporation Information
Table 103. Bayer Description and Major Businesses
Table 104. Bayer Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Bayer Product
Table 106. Bayer Recent Development
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Pfizer Product
Table 111. Pfizer Recent Development
Table 112. Senju Corporation Information
Table 113. Senju Description and Major Businesses
Table 114. Senju Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Senju Product
Table 116. Senju Recent Development
Table 117. Akorn Corporation Information
Table 118. Akorn Description and Major Businesses
Table 119. Akorn Pharma Ophthalmic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Akorn Product
Table 121. Akorn Recent Development
Table 122. Global Pharma Ophthalmic Sales Forecast by Regions (2021-2026) (K Pcs)
Table 123. Global Pharma Ophthalmic Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Pharma Ophthalmic Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Pharma Ophthalmic Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Pharma Ophthalmic Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. North America: Pharma Ophthalmic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Pharma Ophthalmic Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Europe: Pharma Ophthalmic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Pharma Ophthalmic Sales Forecast by Region (2021-2026) (K Pcs)
Table 131. Asia Pacific: Pharma Ophthalmic Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Pharma Ophthalmic Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Latin America: Pharma Ophthalmic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Pharma Ophthalmic Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. Middle East and Africa: Pharma Ophthalmic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Pharma Ophthalmic Players
Table 140. Pharma Ophthalmic Customers List
Table 141. Pharma Ophthalmic Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Ophthalmic Product Picture
Figure 2. Global Pharma Ophthalmic Sales Market Share by Type in 2020 & 2026
Figure 3. Retinal disorders drugs Product Picture
Figure 4. Allergic, inflammatory and infective drugs Product Picture
Figure 5. Glaucoma drugs Product Picture
Figure 6. Dry eye drugs Product Picture
Figure 7. Other ophthalmic drugs Product Picture
Figure 8. Global Pharma Ophthalmic Sales Market Share by Application in 2020 & 2026
Figure 9. Glaucoma
Figure 10. Dry eye syndrome
Figure 11. Retinal diseases
Figure 12. Other ophthalmic indications
Figure 13. Pharma Ophthalmic Report Years Considered
Figure 14. Global Pharma Ophthalmic Market Size 2015-2026 (US$ Million)
Figure 15. Global Pharma Ophthalmic Sales 2015-2026 (K Pcs)
Figure 16. Global Pharma Ophthalmic Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Pharma Ophthalmic Sales Market Share by Region (2015-2020)
Figure 18. Global Pharma Ophthalmic Sales Market Share by Region in 2019
Figure 19. Global Pharma Ophthalmic Revenue Market Share by Region (2015-2020)
Figure 20. Global Pharma Ophthalmic Revenue Market Share by Region in 2019
Figure 21. Global Pharma Ophthalmic Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Pharma Ophthalmic Revenue in 2019
Figure 23. Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Pharma Ophthalmic Sales Market Share by Type (2015-2020)
Figure 25. Global Pharma Ophthalmic Sales Market Share by Type in 2019
Figure 26. Global Pharma Ophthalmic Revenue Market Share by Type (2015-2020)
Figure 27. Global Pharma Ophthalmic Revenue Market Share by Type in 2019
Figure 28. Global Pharma Ophthalmic Market Share by Price Range (2015-2020)
Figure 29. Global Pharma Ophthalmic Sales Market Share by Application (2015-2020)
Figure 30. Global Pharma Ophthalmic Sales Market Share by Application in 2019
Figure 31. Global Pharma Ophthalmic Revenue Market Share by Application (2015-2020)
Figure 32. Global Pharma Ophthalmic Revenue Market Share by Application in 2019
Figure 33. North America Pharma Ophthalmic Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Pharma Ophthalmic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Pharma Ophthalmic Sales Market Share by Country in 2019
Figure 36. North America Pharma Ophthalmic Revenue Market Share by Country in 2019
Figure 37. U.S. Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Pharma Ophthalmic Market Share by Type in 2019
Figure 42. North America Pharma Ophthalmic Market Share by Application in 2019
Figure 43. Europe Pharma Ophthalmic Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Pharma Ophthalmic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Pharma Ophthalmic Sales Market Share by Country in 2019
Figure 46. Europe Pharma Ophthalmic Revenue Market Share by Country in 2019
Figure 47. Germany Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Pharma Ophthalmic Market Share by Type in 2019
Figure 58. Europe Pharma Ophthalmic Market Share by Application in 2019
Figure 59. Asia Pacific Pharma Ophthalmic Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Pharma Ophthalmic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Pharma Ophthalmic Sales Market Share by Region in 2019
Figure 62. Asia Pacific Pharma Ophthalmic Revenue Market Share by Region in 2019
Figure 63. China Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Pharma Ophthalmic Market Share by Type in 2019
Figure 86. Asia Pacific Pharma Ophthalmic Market Share by Application in 2019
Figure 87. Latin America Pharma Ophthalmic Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Pharma Ophthalmic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Pharma Ophthalmic Sales Market Share by Country in 2019
Figure 90. Latin America Pharma Ophthalmic Revenue Market Share by Country in 2019
Figure 91. Mexico Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Pharma Ophthalmic Market Share by Type in 2019
Figure 98. Latin America Pharma Ophthalmic Market Share by Application in 2019
Figure 99. Middle East and Africa Pharma Ophthalmic Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Pharma Ophthalmic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Pharma Ophthalmic Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Pharma Ophthalmic Revenue Market Share by Country in 2019
Figure 103. Turkey Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Pharma Ophthalmic Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Pharma Ophthalmic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Pharma Ophthalmic Market Share by Type in 2019
Figure 110. Middle East and Africa Pharma Ophthalmic Market Share by Application in 2019
Figure 111. North America Pharma Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Pharma Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Pharma Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Pharma Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Pharma Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Pharma Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Pharma Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Pharma Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Pharma Ophthalmic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Pharma Ophthalmic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs